Press Releases
Search
-
14 Dec 2015
bioMérieux and Illumina announce the launch of bioMérieux EpiSeq™, a revolutionary Next-Generation Sequencing service for epidemiological monitoring of bacterial infections
bioMérieux, a world leader in the field of in vitro diagnostics, and Illumina (Nasdaq: ILMN), a world leader in genomics, announce the launch of bioMérieux EpiSeq™, an innovative next-generation seque...
-
04 Nov 2015
bioMérieux introduces GENE-UP®, a new molecular diagnostic solution for food pathogen detection jointly developed with BioFire
New generation PCR system benefits from the combined expertise of bioMérieux, world leader in microbiological food safety control and of BioFire, reputed for its know-how in molecular biology...
-
22 Oct 2015
Information financière du 3e trimestre 2015
Robust growth in nine-month sales: Sales reached €1,412 million Up 18.3% as reported Up 8.3% at constant exchange rates and scope of consolidation Solid momentum in the Americas and EMEA1 regions in t...
-
09 Oct 2015
BioFire Diagnostics receives a de novo clearance by the FDA for the FilmArray® Meningitis/Encephalitis panel continuing its extremely favorable business momentum
FilmArray® expanded menu, with a fourth panel, is the largest available on a molecular biology multiplex platform...
-
24 Sep 2015
BioFire Defense, a bioMérieux company, receives Emergency Use Assessment and Listing for FilmArray® Ebola Test by the World Health Organization
Marcy l’Etoile (France) – September 24, 2015 – BioFire Defense, LLC of Salt Lake City, UT announces that its FilmArray® Ebola test (BioThreat-E test1) has received Emergency Use Assessment and Listing...
-
31 Aug 2015
bioMérieux – First-Half 2015 Results
Strong growth in business €933 million in sales Up 19.5% as reported Up 8.1% like-for-like Sharp 34% improvement in contributive operating income before non-recurring items lifted by strong business m...